Open AccessParasite Viability as a Measure of In Vivo Drug Activity in Preclinical and Early Clinical Antimalarial Drug Assessment
Author(s) -
Georges F. R. Radohery,
Annabelle Walz,
Christin Gumpp,
Mohammed H. Cherkaoui-Rbati,
Nathalie Gobeau,
Jeremy Gower,
Miles P. Davenport,
Matthias Rottmann,
James S. McCarthy,
Joerg J. Moehrle,
Maria Rebelo,
Claudia DemartaGatsi,
David S. Khoury
Publication year - 2022
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00114-22
Subject(s) - parasitemia , in vivo , drug , plasmodium falciparum , pharmacology , artesunate , biology , malaria , metric (unit) , medicine , immunology , microbiology and biotechnology , operations management , economics